Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
Naji Najib, Ph.D.
Advertisement
Articles by Naji Najib, Ph.D.
Advertisement
Latest Updated Articles
Gastric-State-Controlled Bioequivalence StudiesPublished: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
